1. Home
  2. XBIT

as 06-21-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Pharmaceuticals and Biotechnology

Nasdaq

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Founded: 2005 Country:
United States
United States
Employees: N/A City: AUSTIN
Market Cap: 253.1M IPO Year: 2015
Target Price: N/A AVG Volume (30 days): 118.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.02 EPS Growth: N/A
52 Week Low/High: $3.51 - $9.96 Next Earning Date: 08-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

XBIT Daily Stock ML Predictions

Share on Social Networks: